SECTOR GAMMA AS Diversified Active

Location: Oslo, Norway

CIK: 0001475373 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 8, 2023

Total Value: $437M (100.0% shares, 0.0% debt)

Holdings (31)

GILD GILEAD SCIENCES INC 11.7%
Value $51.17M Shares 596,036 Share Price $85.85 * Est. Cost/Share $54.57 Unrealized @ Report Date +29.7%
INCY INCYTE CORP 7.6%
Value $33.05M Shares 411,487 Share Price $80.32 * Est. Cost/Share $73.93 Unrealized @ Report Date +3.5%
CAH CARDINAL HEALTH INC 6.2%
Value $27.2M Shares 353,872 Share Price $76.87 * Est. Cost/Share $47.94 Unrealized @ Report Date +49.3%
BMY BRISTOL-MYERS SQUIBB CO 6.2%
Value $27.17M Shares 377,669 Share Price $71.95 * Est. Cost/Share $47.92 Unrealized @ Report Date +36.1%
ELV ELEVANCE HEALTH INC 5.6%
Value $24.51M Shares 47,777 Share Price $512.97 * Est. Cost/Share $311.68 Unrealized @ Report Date +55.4%
MRK MERCK & CO INC 5.1%
Value $22.11M Shares 199,300 Share Price $110.95 * Est. Cost/Share $66.44 Unrealized @ Report Date +39.7%
MDT MEDTRONIC PLC 4.9%
Value $21.56M Shares 277,435 Share Price $77.72 * Est. Cost/Share $85.79 Unrealized @ Report Date -14.4%
ZBH ZIMMER BIOMET HOLDINGS INC 4.5%
Value $19.65M Shares 154,116 Share Price $127.50 * Est. Cost/Share $113.96 Unrealized @ Report Date -1.0%
BIIB BIOGEN INC 4.4%
Value $19.4M Shares 70,039 Share Price $276.92 Est. Cost/Share $267.48 Unrealized @ Report Date +5.6%
— LABORATORY CORP AMER HLDGS 4.0%
Value $17.54M Shares 74,496 Share Price $235.48 Est. Cost/Share $235.48 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 3.7%
Value $16.04M Shares 155,009 Share Price $103.49 * Est. Cost/Share $85.55 Unrealized @ Report Date +9.7%
CNC CENTENE CORP DEL 3.5%
Value $15.16M Shares 184,901 Share Price $82.01 Est. Cost/Share $66.44 Unrealized @ Report Date +22.9%
— SEAGEN INC 3.1%
Value $13.65M Shares 106,207 Share Price $128.51 Est. Cost/Share $154.34 Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 3.1%
Value $13.64M Shares 294,784 Share Price $46.27 * Est. Cost/Share $31.53 Unrealized @ Report Date +37.3%
BRKR BRUKER CORP 3.0%
Value $13.12M Shares 191,982 Share Price $68.35 * Est. Cost/Share $52.55 Unrealized @ Report Date +19.5%
EW EDWARDS LIFESCIENCES CORP 3.0%
Value $13M Shares 174,252 Share Price $74.61 * Est. Cost/Share $77.07 Unrealized @ Report Date 0.0%
— QIAGEN NV 2.7%
Value $11.64M Shares 233,473 Share Price $49.87 Est. Cost/Share $49.87 Unrealized @ Report Date —
BAX BAXTER INTL INC 2.6%
Value $11.27M Shares 221,088 Share Price $50.97 * Est. Cost/Share $53.97 Unrealized @ Report Date -8.0%
ILMN ILLUMINA INC 2.2%
Value $9.604M Shares 47,500 Share Price $202.20 * Est. Cost/Share $207.24 Unrealized @ Report Date 0.0%
THC TENET HEALTHCARE CORP 2.2%
Value $9.561M Shares 195,954 Share Price $48.79 * Est. Cost/Share $46.22 Unrealized @ Report Date 0.0%
CI CIGNA CORP NEW 1.7%
Value $7.373M Shares 22,252 Share Price $331.34 * Est. Cost/Share $207.88 Unrealized @ Report Date +43.8%
— NUVASIVE INC 1.6%
Value $7.169M Shares 173,842 Share Price $41.24 Est. Cost/Share $56.60 Unrealized @ Report Date —
BIO BIO RAD LABS INC 1.5%
Value $6.723M Shares 15,988 Share Price $420.49 * Est. Cost/Share $257.56 Unrealized @ Report Date +56.7%
IONS IONIS PHARMACEUTICALS INC 1.2%
Value $5.34M Shares 141,373 Share Price $37.77 * Est. Cost/Share $54.18 Unrealized @ Report Date -22.4%
CVS CVS HEALTH CORP 0.9%
Value $4.048M Shares 43,443 Share Price $93.19 * Est. Cost/Share $57.80 Unrealized @ Report Date +48.7%
BNTX BIONTECH SE 0.8%
Value $3.566M Shares 23,738 Share Price $150.22 Est. Cost/Share $150.22 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 0.8%
Value $3.309M Shares 86,692 Share Price $38.17 * Est. Cost/Share $38.55 Unrealized @ Report Date +7.8%
ACAD ACADIA PHARMACEUTICALS INC 0.7%
Value $2.958M Shares 185,835 Share Price $15.92 Est. Cost/Share $15.63 Unrealized @ Report Date 0.0%
— CATALENT INC 0.6%
Value $2.476M Shares 55,000 Share Price $45.01 Est. Cost/Share $45.01 Unrealized @ Report Date —
VIR VIR BIOTECHNOLOGY INC 0.5%
Value $2.273M Shares 89,808 Share Price $25.31 * Est. Cost/Share $31.74 Unrealized @ Report Date -22.8%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.5%
Value $2.109M Shares 45,520 Share Price $46.33 * Est. Cost/Share $69.58 Unrealized @ Report Date -43.5%